Satoshi Okoso

Mebix, Inc. is engaged in the development and marketing of clinical trial support systems. The company's activities are carried out through evidence solutions, site support, and cell science. The firm is also involved in providing clinical trial support service and medical equipment development and sales. Mebix was founded by Yasuhiko Yoshida on May 21, 2001 and is headquartered in Tokyo, Japan.

Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.

Sogo Rinsho Holdings Co., Ltd. manages site management organization (SMO) engaged in providing support services for medical institutions conducting clinical trials. Its services include clinical research coordinator services, institutional review board secretariat services, secretariat services for clinical trials, and clinical trial quality assurance and quality control. The company was founded on December 20, 1989 and is headquartered in Tokyo, Japan.

EPS Group, Inc. provides professional consulting services to public and private clients. Its services include land development, public works, planning, survey, landscape architecture, and construction management. The company was founded on June 30, 2003 and is headquartered in Mesa, AZ.

EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin, and Others. The CRO segment offers clinical trials, data management, and statistical analysis. The SMO segment enters into contracts with medical institutions to conduct clinical trials. The CSO segment provides drug information and awareness for medical and pharmaceutical industries. The Global Research segment provides consignment services through its subsidiary for multilateral clinical trials in Asia-Pacific. The Ekishin segment focuses on medical equipment, pharmaceutical and investment related businesses through its Japan and China based subsidiaries. The Others segment provides various services related to management of clinical research from business processing outsource business related to medicine and medical care. The company was founded on May 30, 1991 and is headquartered in Tokyo, Japan.